|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Blood Disease | |||||
| Hepatitis, Viral, Human | |||||
| Liver Diseases | |||||
| Hemophilia A | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hematologic Diseases | |||||
| Hepatitis | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Coagulation Disorders | |||||
| Blood Coagulation Disorders, Inherited | |||||
| Coagulation Protein Disorders | |||||
| Digestive System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Hemorrhagic Disorders | |||||
| Virus Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||